Catherine M. Szyman insider trades

Open-market stock purchases and sales by Catherine M. Szyman, Chief Executive Officer at Masimo Corp, from SEC Form 4 filings since Feb 19, 2015.

Track record: 100% of 2 scored buys are up 5% or more since purchase, averaging +6%.

Recent trades

DateStockTradeValue
Jun 10, 2026MASI Masimo CorpSold (not open market)$1.4M
Jun 10, 2026MASI Masimo CorpSold (not open market)—
Jun 10, 2026MASI Masimo CorpSold (not open market)—
Jun 10, 2026MASI Masimo CorpSold (not open market)—
Jun 10, 2026MASI Masimo CorpSold (not open market)$251K
Jun 10, 2026MASI Masimo CorpSold (not open market)$8.9M
Mar 11, 2026MASI Masimo CorpSold (not open market)$188K
Mar 11, 2026MASI Masimo CorpBought (not open market)—
Mar 6, 2026MASI Masimo CorpBought (not open market)—
Feb 12, 2026MASI Masimo CorpSold (not open market)—
Feb 12, 2026MASI Masimo CorpBought (not open market)—

Companies traded

  • MASI Masimo Corp: other filings, last Jun 10, 2026
  • NARI Inari Medical, Inc: 1 buy, last Feb 19, 2025
  • EW Edwards Lifesciences Corp: 2 buys, 76 sales, last Sep 3, 2024
  • OM Outset Medical, Inc: other filings, last May 31, 2023

Get free alerts when Catherine M. Szyman files a new trade →